Search research articles
Contact Us
Filters
Showing results (1-10 of 90) with videos related to
Page
of 9
Sort By:
COPD
|
May 17, 2012
Sildenafil for COPD: a randomized crossover trial
Todd Bull, David B Badesch
Annals of Internal Medicine
|
August 17, 2005
Evaluation and management of the patient with pulmonary arterial hypertension
Lewis J Rubin, David B Badesch
Progress in Cardiovascular Diseases
|
January 15, 2003
Pulmonary hypertension associated with connective tissue disease
Karen A Fagan, David B Badesch
American Journal of Respiratory and Critical Care Medicine
|
March 31, 2021
Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer
Lindsay M Forbes, Sue Gu, David B Badesch
Rheumatic Diseases Clinics of North America
|
August 9, 2005
Pulmonary vascular manifestations of mixed connective tissue disease
Todd M Bull, Karen A Fagan, David B Badesch
Current Hypertension Reports
|
May 4, 2016
Anticoagulation in Pulmonary Arterial Hypertension
Jeffrey C Robinson, Steven C Pugliese, Daniel L Fox, et al.
Chest
|
December 24, 2005
Metastatic cancer while receiving continuous prostacyclin therapy
Karen A Fagan, Todd M Bull, David B Badesch, et al.
Current Medical Research and Opinion
|
January 30, 2007
Potassium and phosphorus repletion in hospitalized patients: implications for clinical practice and the potential use of healthcare information technology to improve prescribing and patient safety
Brian A Hemstreet, Nancy Stolpman, David B Badesch, et al.
The Annals of Pharmacotherapy
|
May 15, 2008
Formulary management of recombinant factor VIIa at an academic medical center
Phillip S Owen, Larry K Golightly, Robert MacLaren, et al.
Chest
|
June 15, 2007
Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines
David B Badesch, Steven H Abman, Gerald Simonneau, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 90) with videos related to
Sort By:
Page
of 9
COPD
|
May 17, 2012
Sildenafil for COPD: a randomized crossover trial
Todd Bull, David B Badesch
Annals of Internal Medicine
|
August 17, 2005
Evaluation and management of the patient with pulmonary arterial hypertension
Lewis J Rubin, David B Badesch
Progress in Cardiovascular Diseases
|
January 15, 2003
Pulmonary hypertension associated with connective tissue disease
Karen A Fagan, David B Badesch
American Journal of Respiratory and Critical Care Medicine
|
March 31, 2021
Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer
Lindsay M Forbes, Sue Gu, David B Badesch
Rheumatic Diseases Clinics of North America
|
August 9, 2005
Pulmonary vascular manifestations of mixed connective tissue disease
Todd M Bull, Karen A Fagan, David B Badesch
Current Hypertension Reports
|
May 4, 2016
Anticoagulation in Pulmonary Arterial Hypertension
Jeffrey C Robinson, Steven C Pugliese, Daniel L Fox, et al.
Chest
|
December 24, 2005
Metastatic cancer while receiving continuous prostacyclin therapy
Karen A Fagan, Todd M Bull, David B Badesch, et al.
Current Medical Research and Opinion
|
January 30, 2007
Potassium and phosphorus repletion in hospitalized patients: implications for clinical practice and the potential use of healthcare information technology to improve prescribing and patient safety
Brian A Hemstreet, Nancy Stolpman, David B Badesch, et al.
The Annals of Pharmacotherapy
|
May 15, 2008
Formulary management of recombinant factor VIIa at an academic medical center
Phillip S Owen, Larry K Golightly, Robert MacLaren, et al.
Chest
|
June 15, 2007
Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines
David B Badesch, Steven H Abman, Gerald Simonneau, et al.
Page
of 9